Navigation Links
Alpha and Omega Gene Therapy Eye Cream's Scientific Blend Removes Years of Damage

PHILADELPHIA, Dec. 19, 2013 /PRNewswire/ -- E'Shee Clinical Esthetic announced the launch of a new eye cream product that is designed to target wrinkles, sagging skin, dark circles and puffiness. But, unlike other eye creams, this Alpha and Omega gene therapy eye cream is a scientifically-advanced blend of innovative ingredients.       


"Supremely-advanced restoration and care for the eyes and lips is what this product delivers," Nataly Giter, founder, E'shee Clinical Esthetic, says.  

E'shee's eye cream has a light creamy texture and includes ingredients such as patented aFGF (acidic fibroblast growth factor), far-infrared powder and Botox-like peptides. It's designed for the most delicate facial skin and works to remove years and years of skin damage and negligence.

aFGF is a bioengineered growth factor identical to the natural growth factor found in the human body and can provide fast, skin-repairing effects while dramatically speeding up the skin-renewal process. And, far infrared powder, produced from natural elements, can absorb outside heat energy and then release it. It recharges aging or dying cells which may explain why a far infrared ray with this healing wavelength is called "life light."

In addition to the usual benefits of fine line disappearance, deep wrinkle reduction and firmer and healthier skin, gene therapy eye cream users will also realize better texture; rebuild extra cellular matrix and restore its function; and reduce puffiness through improved blood circulation and toxin removal.

Alpha and Omega gene therapy cream also works to reduce redness caused by rosacea; helps to repair broken capillaries; and can help to heal scar tissue resulting from burns or acne.

"Stronger and improved skin is typically seen within 28 days," Giter says.

E'Shee Clinical Esthetic recommends this gene therapy eye cream for all skin types and ages. It's a non-greasy and fast-absorbing formula that does not clog pores.

About E'shee Clinical Esthetic:

E'shee was launched in 2009 by Nataly Giter, a hands-on skin care professional with more than 20 years of experience. Through research and practical experience, she learned about the most effective ingredients for advanced skin care and became associated with Dr. Chiu, a professor from Ohio University and the first global pioneer to clone the human FGF-1 gene.

Together, with their combined connections to industry professionals, they used FGF-1 to create an extraordinary anti-aging product line, using 99 percent pure FGF-1 peptide - the best quality available outside of the human body.

For more information on E'shee Clinical Esthetic, visit: or

- Photo 72dpi:

- Photo Caption: Alpha and Omega Gene Therapy Eye Cream.

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at

SOURCE E'shee Clinical Esthetic
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alpha Imaging Acquires Tristar Midatlantic Imaging
2. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
3. The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinsons Disease Biomarker
4. Harrisvaccines, Inc. Secures Exclusive Rights From AlphaVax, Inc. to Develop RNA Particle Vaccines for All Diseases in Companion Animals
5. Uroplasty To Participate In The Craig-Hallum Alpha Select Conference
6. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
7. Cardica To Present At Craig-Hallum Alpha Select Conference
8. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
9. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
10. CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators
11. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
Post Your Comments:
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):